Bhumyamalaki and Pregnancy: What the Only Study in Pregnant Rats Shows
Bhumyamalaki is one of the rare Ayurvedic liver herbs directly evaluated during gestation in animals — here is what that study shows, and why caution still applies.
Bhumyamalaki (Phyllanthus niruri / amarus) is to be avoided as a precaution during pregnancy, as our bhumyamalaki dangers article already notes. This herb is one of the rare members of the Ayurvedic liver pharmacopoeia to have been tested directly in pregnant females in a laboratory setting — a fact rare enough to be worth detailing here.
What the study in pregnant rats shows
A study published in 2020 in the Journal of Ethnopharmacology administered an aqueous extract of Phyllanthus niruri to pregnant rats from the first to the last day of gestation, at several dose levels (see the study on Google Scholar). Result: no clear teratogenic effect and no major alteration of overall reproductive performance. However, at the highest dose tested, the researchers observed fetal macrosomia (increased birth weight), increased ossification in the fetuses, and changes in maternal kidney weight and morphology.
This result is more nuanced than alarming: it shows no malformation, but it confirms that the herb crosses the maternal-fetal barrier and alters physiological parameters at high doses. That is exactly the kind of signal that justifies keeping a precautionary contraindication, even in the absence of clear toxicity.
Summary
| Situation | Recommendation |
|---|---|
| Pregnancy, any dose | Avoid as a precaution; effects on fetal weight and maternal kidneys observed at high dose in animals. |
| Breastfeeding | Insufficient data; caution recommended. |
| Liver condition diagnosed during pregnancy | Never self-manage; medical follow-up required, bhumyamalaki is not a substitute treatment. |
A nuance that changes nothing about the recommended approach
The absence of a clear teratogenic effect in this study should not be read as a green light: a single animal study, at standardized doses not directly transposable to humans, is never enough to establish safety in pregnant women. Consistency with the caution already recommended in bhumyamalaki dangers therefore remains the rule.
Precautions
For an overview of practices to avoid during pregnancy, see our Ayurveda and pregnancy guide. General precautionary principles applicable to every herb on this site are listed in the safety and precautions guide. Any liver-related question during pregnancy calls for medical advice, never plant-based self-treatment.
Your questions about bhumyamalaki and pregnancy
Does the study in pregnant rats reassure us about bhumyamalaki in pregnancy?
Only partly. It did not show a clear malformation, but it did observe fetal macrosomia and maternal kidney changes at high dose, which justifies maintaining caution rather than lifting it.
Can bhumyamalaki be taken for the liver during pregnancy?
No, as a precaution. Liver issues during pregnancy need to be assessed and medically followed, never managed by self-treating with an herb not validated for this period.
Is bhumyamalaki compatible with breastfeeding?
Safety data specific to breastfeeding are insufficient. Caution recommends avoiding this herb during this period too, unless a healthcare professional advises otherwise.
Was this study conducted in pregnant women?
No, it was conducted in rats, an animal model whose results do not transpose directly to humans. That is precisely why no definitive safety conclusion can be drawn from it for pregnant women.
Free guide
Your 7-step Ayurvedic morning routine
The condensed dinacharya: seven realistic steps with timings, the 15-minute weekday version and dosha adjustments. Enter your email and read it right away — no PDF to hunt for, no spam.